Double-J PLUS Ureteral Stent Patient Registry

Overview

About this study

The purpose of this study is to obtain postmarket safety and efficacy data on Boston Scientific Double-J Ureteral Stents.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Subject is undergoing placement of a Boston Scientific Double-J Ureteral Stent.
  • Subject anatomy is appropriate to accommodate a stent size available in the study.
  • Subject is able to accurately detect and report bladder function and pain.
  • Subject is willing and able to:
    • Complete patient QoL questionnaire at specified time points (for subjects aged ≥ 18 years) and return for all follow-up visits. 

Exclusion Criteria:

  • Subjects who meet any of the contraindications per individual stent directions for use (DFU).
  • Subjects receiving different stent type in case of bilateral/multiple stenting.
  • Subjects with an indwelling ureteral stent(s) not planned to be removed prior to/or concurrently with the study stent implant.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Mitchell Humphreys, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available
.
CLS-20507813

Mayo Clinic Footer